HEPARIN Side Effects

6678249-7 | Activated Partial Thromboplastin Time Abnormal
on Apr 08, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with surgery (What is surgery?), transplant and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time abnormal. Heparin dosage: 1000 Units Per Hour Iv.

6678235-7 | Activated Partial Thromboplastin Time Prolonged
Patient was taking Heparin (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged on Apr 08, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 220.5 lb, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Heparin dosage: Varied Continuous Infusion Iv.

6672129-9 | Heparin-induced Thrombocytopenia, Renal Failure Acute, Thrombosis, Toe Amputation
Adverse event was reported on Apr 07, 2010 by a Male patient taking Heparin (View Usage) (Dosage: 1500-1750 Units Per Hour Iv Drip) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 56 years of age, weighting 220.5 lb, After Heparin was administered, patient had the following side effects: heparin-induced thrombocytopenia, renal failure acute, thrombosis, toe amputation. Patient was hospitalized.

6663625-9 | Coronary Artery Bypass, Dyspnoea, Ecchymosis, Face Oedema, Haematoma, Haemoglobin Decreased, Oedema Peripheral, Orthopnoea, Pain In Extremity
on Mar 31, 2010 Male patient from UNITED STATES , 55 years of age, weighting 185.2 lb, was diagnosed with cardiac valve prosthesis user and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery bypass (What is coronary artery bypass?), dyspnoea, ecchymosis, face oedema, haematoma, haemoglobin decreased, oedema peripheral, orthopnoea, pain in extremity. Heparin dosage: 1000 Units/hr -15 Mg/kg/hr- Continuous Iv Drip. During the same period patient was treated with WARFARIN SODIUM (2mg Daily Po) (View Warfarin Sodium Review and Warfarin Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ), MORPHINE (View Morphine Review and Morphine Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.


6659825-4 | Thrombocytopenia
on Mar 30, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Heparin (View Usage). Patient had the following side effects: thrombocytopenia. Heparin dosage: 5000 Units Tid Sq. Patient was hospitalized.

6655570-X | Abdominal Wall Haematoma, Cellulitis, Ecchymosis, Haemoglobin Decreased, Haemorrhage, Thrombocytopenia
Patient was taking Heparin (View Usage). After Heparin was administered, patient had the following side effects: abdominal wall haematoma, cellulitis (What is cellulitis?), ecchymosis, haemoglobin decreased, haemorrhage, thrombocytopenia on Mar 26, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 203.0 lb, was diagnosed with thrombosis prophylaxis, infection (What is infection?) and. Heparin dosage: 5000 Units Tid Sq. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM (4.5 Gm Qid Iv) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ). Patient was hospitalized.

6647607-9 | Cyanosis, Heparin-induced Thrombocytopenia, Hepatic Function Abnormal, Metabolic Acidosis, Posturing
Adverse event was reported on Mar 23, 2010 by a Male patient taking Heparin (View Usage) (Dosage: 5000 Units Tid Sq) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: UNITED STATES , 84 years of age, weighting 178.8 lb, Patient experienced the following unwanted or unexpected effects: cyanosis, heparin-induced thrombocytopenia, hepatic function abnormal, metabolic acidosis, posturing.

6647450-0 | Heparin-induced Thrombocytopenia
on Mar 23, 2010 Male patient from UNITED STATES , 70 years of age, weighting 194.0 lb, was treated with Heparin (View Usage). Patient had the following side effects: heparin-induced thrombocytopenia. Heparin dosage: 1000-4200 Units Daily Hemodialysi.

6647170-2 | Thrombocytopenia
on Mar 22, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with prophylaxis and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: thrombocytopenia. Heparin dosage: 5000 Units Tid Sq.

6641608-2 | Activated Partial Thromboplastin Time Prolonged, Haemoglobin Decreased, Incorrect Dose Administered
Patient was taking Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, haemoglobin decreased, incorrect dose administered on Mar 17, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 130.1 lb, was diagnosed with prophylaxis and. Heparin dosage: 30,000 Units Once Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

6641554-4 | Heparin-induced Thrombocytopenia, Renal Impairment
Adverse event was reported on Mar 17, 2010 by a Female patient taking Heparin (View Usage) (Dosage: 5000 Units Q8o Sq) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 75 years of age, weighting 125.7 lb, Patient had the following side effects: heparin-induced thrombocytopenia, renal impairment. During the same period patient was treated with APAP TAB (View Apap Tab Review and Apap Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DOCUSATE (View Docusate Review and Docusate Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ).

6641534-9 | Heparin-induced Thrombocytopenia
on Mar 17, 2010 Male patient from UNITED STATES , 60 years of age, weighting 178.1 lb, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: heparin-induced thrombocytopenia. Heparin dosage: 15unit/kg/hr Continuous Infusion Iv. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ODANSETRON (View Odansetron Review and Odansetron Label ).

6620242-4 | Heparin-induced Thrombocytopenia
on Mar 08, 2010 Male patient from UNITED STATES , 55 years of age, weighting 242.5 lb, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: heparin-induced thrombocytopenia. Heparin dosage: 5000 Units Tid Sq. During the same period patient was treated with DEXTROSE/HEPARIN (2000 Units Per Hour Iv) (View Dextrose/heparin Review and Dextrose/heparin Label ). Patient was hospitalized.

6614136-8 | Heparin-induced Thrombocytopenia, Skin Necrosis
Patient was taking Heparin (View Usage). Patient had the following side effects: heparin-induced thrombocytopenia, skin necrosis on Mar 03, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 212.1 lb, . Heparin dosage: 18 Units/kg/hr Infusion Iv. During the same period patient was treated with WARFARIN SODIUM (3 Mg Qhs Po) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6596508-3 | Thrombocytopenia
Adverse event was reported on Feb 22, 2010 by a Male patient taking Heparin (View Usage) (Dosage: 5000 Units Other Sq) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 62 years of age, weighting 183.0 lb, After Heparin was administered, patient had the following side effects: thrombocytopenia. Patient was hospitalized.

6595313-1 | Deep Vein Thrombosis, Heparin-induced Thrombocytopenia
on Feb 19, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia. Heparin dosage: 5000 Units Q8h Sq. During the same period patient was treated with TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), NEXIUM (View Nexium Review and Nexium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), SINGULAIR (View Singulair Review and Singulair Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), LIORESAL (View Lioresal Review and Lioresal Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

6594545-6 | Thrombocytopenia
on Feb 18, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Heparin (View Usage). Patient had the following side effects: thrombocytopenia. Heparin dosage: 5000 Units Tid Sq.

6594047-7 | Anti-platelet Antibody Positive, Thrombocytopenia
Patient was taking Heparin (View Usage). After Heparin was administered, patient had the following side effects: anti-platelet antibody positive, thrombocytopenia on Feb 18, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Heparin dosage: 1000 Units Per Hour Iv.

6594016-7 | Heparin-induced Thrombocytopenia
Adverse event was reported on Feb 18, 2010 by a Female patient taking Heparin (View Usage) (Dosage: 144 Units Per Iv) was diagnosed with atrial fibrillation (What is atrial fibrillation?), deep vein thrombosis (What is deep vein thrombosis?) and. Location: UNITED STATES , 72 years of age, Patient experienced the following unwanted or unexpected effects: heparin-induced thrombocytopenia.

6593949-5 | Thrombocytopenia
on Feb 18, 2010 Male patient from UNITED STATES , 81 years of age, weighting 138.9 lb, was treated with Heparin (View Usage). Patient had the following side effects: thrombocytopenia. Heparin dosage: 5000 Units Tid Sq. Patient was hospitalized.

6593067-6 | Thrombocytopenia
on Feb 18, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with acute coronary syndrome and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: thrombocytopenia. Heparin dosage: 13 Ml Per Hour Iv.

6588277-8 | Thrombocytopenia
Patient was taking Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia on Feb 17, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 232.9 lb, was diagnosed with thrombosis prophylaxis and. Heparin dosage: . Patient was hospitalized.

6585968-X | Product Measured Potency Issue
Adverse event was reported on Feb 16, 2010 by a Male patient taking Heparin (View Usage) (Dosage: 12000 Units Iv) was diagnosed with angiogram and. Location: UNITED STATES , weighting 176.4 lb, Patient had the following side effects: product measured potency issue. Patient was hospitalized.

6582615-8 | Erythema Multiforme, Injection Site Necrosis, Purpura, Rash Morbilliform, Thrombocytopenia
on Feb 12, 2010 Male patient from UNITED STATES , 75 years of age, weighting 134.9 lb, was diagnosed with cerebrovascular accident prophylaxis, convulsion and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: erythema multiforme, injection site necrosis, purpura, rash morbilliform, thrombocytopenia. Heparin dosage: 5000 Units Other Sq. During the same period patient was treated with PHENYTOIN (230 Mg Hs Po) (View Phenytoin Review and Phenytoin Label ).

6582536-0 | Thrombocytopenia
on Feb 12, 2010 Male patient from UNITED STATES , 58 years of age, weighting 138.9 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Heparin dosage: 5000 Units Tid Sq. Patient was hospitalized.

6582526-8 | Thrombocytopenia
Patient was taking Heparin (View Usage). Patient had the following side effects: thrombocytopenia on Feb 12, 2010 from UNITED STATES Additional patient health information: Male patient , 81 years of age, weighting 289.9 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Heparin dosage: 15 Ml Per Hour Iv. Patient was hospitalized.

6554984-6 | Epistaxis
Adverse event was reported on Jan 26, 2010 by a Female patient taking Heparin (View Usage) (Dosage: 19 Unit/kg/hr Continuous Drip Iv Drip) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 67 years of age, After Heparin was administered, patient had the following side effects: epistaxis. Patient was hospitalized and became disabled.

6553893-6 | Therapeutic Response Decreased
on Jan 25, 2010 Male patient from UNITED STATES , 61 years of age, was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: therapeutic response decreased. Heparin dosage: -1,000units/500ml/iv.

6545932-3 | Deep Vein Thrombosis, Heparin-induced Thrombocytopenia
on Jan 21, 2010 Female patient from UNITED STATES , 44 years of age, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia. Heparin dosage: .

6544666-9 | Atrial Fibrillation, Emotional Distress, Heparin-induced Thrombocytopenia, Myocardial Infarction, Product Contamination, Pulmonary Thrombosis, White Clot Syndrome
Patient was taking Heparin (View Usage). After Heparin was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), emotional distress, heparin-induced thrombocytopenia, myocardial infarction, product contamination, pulmonary thrombosis, white clot syndrome on Jan 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 191.0 lb, . Heparin dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6542759-3 | Activated Partial Thromboplastin Time Prolonged, Device Malfunction, Infusion Site Haematoma, Medical Device Complication, Overdose
Adverse event was reported on Jan 04, 2010 by a Female patient taking Heparin (View Usage) (Dosage: 400 Ml, Intravenous) was diagnosed with cardiac disorder and. Location: UNITED STATES , 95 years of age, Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, device malfunction, infusion site haematoma, medical device complication, overdose.

6539014-4 | Heparin-induced Thrombocytopenia, Multi-organ Failure
on Jan 13, 2010 Male patient from UNITED STATES , weighting 193.0 lb, was diagnosed with cardiac operation, endarterectomy and was treated with Heparin (View Usage). Patient had the following side effects: heparin-induced thrombocytopenia, multi-organ failure. Heparin dosage: . Patient was hospitalized and became disabled.

6531998-3 | Atrial Fibrillation, Bradycardia, Gouty Arthritis, Haemodialysis, Hypotension, Leukaemoid Reaction, Mental Status Changes, Renal Tubular Necrosis, Respiratory Distress
on Jan 07, 2010 Male patient from UNITED STATES , 70 years of age, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, gouty arthritis, haemodialysis, hypotension, leukaemoid reaction, mental status changes, renal tubular necrosis, respiratory distress. Heparin dosage: Bid Sq. Patient was hospitalized.

6531818-7 | No Adverse Event
Patient was taking Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event on Jan 07, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.0 lb, . Heparin dosage: 6,000 Units Once Iv Bolus. During the same period patient was treated with DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), VERSED (View Versed Review and Versed Label ).

6531527-4 | Heparin-induced Thrombocytopenia, Thrombosis
Adverse event was reported on Jan 07, 2010 by a Male patient taking Heparin (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, Patient had the following side effects: heparin-induced thrombocytopenia, thrombosis.

6523969-8 | Brain Oedema, Cerebellar Haemorrhage, Intracranial Pressure Increased, Photophobia, Visual Impairment
on Dec 30, 2009 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with peripheral ischaemia and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: brain oedema, cerebellar haemorrhage, intracranial pressure increased, photophobia, visual impairment. Heparin dosage: 1050 Units/hr Iv Drip. Patient was hospitalized.

6523894-2 | Heparin-induced Thrombocytopenia
on Dec 30, 2009 Male patient from UNITED STATES , 54 years of age, weighting 405.7 lb, was diagnosed with prophylaxis, deep vein thrombosis (What is deep vein thrombosis?) and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: heparin-induced thrombocytopenia. Heparin dosage: 5000 Units Sq Q8hours. During the same period patient was treated with APAP TAB (View Apap Tab Review and Apap Tab Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6522502-4 | Brain Herniation, Brain Oedema, Confusional State, Headache, Intracranial Venous Sinus Thrombosis, Muscle Twitching, Retinal Haemorrhage, Superior Sagittal Sinus Thrombosis, Transverse Sinus Thrombosis
Patient was taking Heparin (View Usage). Patient had the following side effects: brain herniation, brain oedema, confusional state, headache (What is headache?), intracranial venous sinus thrombosis, muscle twitching, retinal haemorrhage, superior sagittal sinus thrombosis, transverse sinus thrombosis on Dec 29, 2009 from UNITED STATES Additional patient health information: Female patient , 23 years of age, weighting 271.2 lb, was diagnosed with intracranial venous sinus thrombosis and. Heparin dosage: 1250 Units/hr Iv Drip.

6522233-0 | Injection Site Haemorrhage, Prothrombin Time Prolonged
Adverse event was reported on Dec 29, 2009 by a Male patient taking Heparin (View Usage) (Dosage: 5000 U Sq Q8 Hours) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), prophylaxis and. Location: UNITED STATES , 65 years of age, weighting 116.2 lb, After Heparin was administered, patient had the following side effects: injection site haemorrhage, prothrombin time prolonged. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), MORPHINE (View Morphine Review and Morphine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6522187-7 | Catheter Site Haemorrhage, Central Nervous System Lesion, Platelet Count Decreased, Septic Shock, Subarachnoid Haemorrhage
on Dec 29, 2009 Male patient from UNITED STATES , 64 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), thrombosis prophylaxis and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site haemorrhage, central nervous system lesion, platelet count decreased, septic shock, subarachnoid haemorrhage. Heparin dosage: 5000 Sc Tid; Infusion.

6522184-1 | Haemoglobin Decreased, Hypotension, Retroperitoneal Haemorrhage, Unresponsive To Stimuli
on Dec 29, 2009 Female patient from UNITED STATES , 84 years of age, weighting 165.3 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Heparin (View Usage). Patient had the following side effects: haemoglobin decreased, hypotension, retroperitoneal haemorrhage, unresponsive to stimuli. Heparin dosage: 750 Units/hr Iv. During the same period patient was treated with ATORVASTATIEN (View Atorvastatien Review and Atorvastatien Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6519624-0 | Oesophageal Obstruction
Patient was taking Heparin (View Usage). After Heparin was administered, patient had the following side effects: oesophageal obstruction on Dec 17, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 67 years of age, was diagnosed with myocardial infarction and. Heparin dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), TENECTEPLASE (View Tenecteplase Review and Tenecteplase Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), LOSARTAN (View Losartan Review and Losartan Label ).

6518117-4 | Heparin-induced Thrombocytopenia
Adverse event was reported on Dec 23, 2009 by a Male patient taking Heparin (View Usage) (Dosage: 5000 Units Bid Sq) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: UNITED STATES , 72 years of age, weighting 142.6 lb, Patient experienced the following unwanted or unexpected effects: heparin-induced thrombocytopenia.

6517929-0 | No Adverse Event
on Dec 23, 2009 Female patient from UNITED STATES , weighting 123.9 lb, was treated with Heparin (View Usage). Patient had the following side effects: no adverse event. Heparin dosage: 5,000 Units Once Iv Bolus.

6509377-4 | Muscle Haemorrhage, Musculoskeletal Pain, Pain In Extremity
on Dec 18, 2009 Female patient from UNITED STATES , 56 years of age, weighting 200.0 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: muscle haemorrhage, musculoskeletal pain, pain in extremity. Heparin dosage: 1300 Units/hr Continuous Iv Drip. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), OSCAL (View Oscal Review and Oscal Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), NEXIUM (View Nexium Review and Nexium Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

6509361-0 | Haematoma
Patient was taking Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma on Dec 18, 2009 from UNITED STATES Additional patient health information: Male patient , 25 years of age, weighting 193.3 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Heparin dosage: 2800 Units /hr 43ml/hr Iv Drip. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), BENZONATATE (View Benzonatate Review and Benzonatate Label ), NEXIUM (View Nexium Review and Nexium Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ROBITUSSIN (View Robitussin Review and Robitussin Label ). Patient was hospitalized.

6509080-0 | Alopecia, Cervical Incompetence, Pregnancy
Adverse event was reported on Dec 18, 2009 by a Female patient taking Heparin (View Usage) (Dosage: ) . Location: UNITED STATES , 44 years of age, weighting 175.0 lb, Patient had the following side effects: alopecia, cervical incompetence, pregnancy (What is pregnancy?).

6499851-1 | Embolic Stroke, Haemorrhage Intracranial, Intracardiac Thrombus
on Dec 14, 2009 Female patient from UNITED STATES , 71 years of age, was diagnosed with thrombosis, prophylaxis and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: embolic stroke, haemorrhage intracranial, intracardiac thrombus. Heparin dosage: Variable Continuous Iv Drip. During the same period patient was treated with ASPIRIN (325 Mg Daily Po) (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EPTIFIBATIDE DRIP (View Eptifibatide Drip Review and Eptifibatide Drip Label ), ENOXAPARIN (View Enoxaparin Review and Enoxaparin Label ). Patient was hospitalized.

6493031-1 | Platelet Count Decreased
on Dec 11, 2009 Female patient from UNITED STATES , 50 years of age, weighting 156.5 lb, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Heparin dosage: 100 Units Daily Iv. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), KEPPRA (View Keppra Review and Keppra Label ), BETHANECHOL (View Bethanechol Review and Bethanechol Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6456752-2 | Acute Respiratory Distress Syndrome, Hypotension, Multi-organ Failure, Pulmonary Haemorrhage, Unresponsive To Stimuli
Patient was taking Heparin (View Usage). Patient had the following side effects: acute respiratory distress syndrome, hypotension, multi-organ failure, pulmonary haemorrhage, unresponsive to stimuli on Oct 16, 2009 from UNITED STATES Additional patient health information: Female patient , 48 years of age, . Heparin dosage: .